GeneFormatics Expects to Announce Slew of Deals in Near Future | GenomeWeb

NEW YORK, Oct. 4 – GeneFormatics, which announced a major deal with three Bruker affiliates on Wednesday, expects to unveil a number of deals towards the end of the month designed to further enhance its technological capabilities as it looks for ways to improve the drug discovery process.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.